๐Ÿ”Š CEOInterviews
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Elad Aharonson

President & CEO, Icl

Search every verified Elad Aharonson interview, podcast appearance, and on-the-record quote โ€” each transcript cross-checked by AI and human review to confirm speaker identity. At ICL's October 2022 Investor Day, President and CEO Elad Aharonson stated that the company had already reached its 2025 targets two years early, attributing this to successful acquisitions in Brazil and their integration. He noted that Brazil, China, and India account for 70 percent of growth in the specialty plant nutrition market, and said ICL is focused on those countries. Aharonson outlined new targets for 2027, aiming for $4.25 billion in sales and EBITDA of more than $750 million, with the goal of becoming the global leader in specialty plant nutrition. He also said that in a normal year, EBITDA would track around 15 percent, with the underlying business growing margins over time despite commodity impacts.

Selected quotes

Recent appearances